Search filters

List of works by Barbara Toffoli

Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).

scientific article published in July 2012

Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma

scientific article published on 2 November 2011

Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System

scientific article published on 14 December 2016

Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.

scientific article published on 28 February 2018

Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo

scientific article published on 11 November 2009

Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes

scientific article published on 3 July 2014

Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets

Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop

scientific article published on 27 May 2011

Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB.

scientific article

Potential role of TRAIL in the management of autoimmune diabetes mellitus

scientific article published on January 2012

Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure

scientific article published on 01 September 2010

Renal mineralocorticoid receptor expression is reduced in lipoatrophy

scientific article published on 18 January 2019

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

scientific article

Sex Differences in Proatherogenic Cytokine Levels

scientific article published on 29 May 2020

Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system.

scientific article published in February 2011

Systemic Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery Shows Antiatherosclerotic Activity in Apolipoprotein E–Null Diabetic Mice

scientific article published on 25 September 2006

TRAIL shows potential cardioprotective activity

The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40.

scientific article published on 25 April 2013

Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes

scientific article